$ABBV · AbbVie Inc.

AbbVie Inc. filed a Form 3 with the SEC on October 23, 2026, for John Carethers. The form is an initial statement of beneficial ownership required under Section 16(a) of the Securities Exchange Act of 1934, and it identifies him as a director of AbbVie. The event requiring the statement occurred on October 14, 2026.

The filing reports that John Carethers beneficially owned no non-derivative or derivative securities of AbbVie at that time. The explanation section states simply that no securities are beneficially owned, leaving the ownership tables blank.

The form was signed by an attorney-in-fact on behalf of John Carethers. It establishes his initial ownership status as a newly reporting director, indicating that he held no AbbVie securities as of the reported date.